TickerKhojComparison · NSE · data 2026-11-03
Mangalam Drugs & Organics Ltd. vs Sunrest Lifescience Limited
In plain words
Size: Mangalam Drugs & Organics Ltd. is about 2.7 times the market value of Sunrest Lifescience Limited.
Return on equity: Sunrest Lifescience Limited 22.4% vs Mangalam Drugs & Organics Ltd. -35.2%.
Debt to equity: Mangalam Drugs & Organics Ltd. 1.08 vs Sunrest Lifescience Limited 0.85.
Differences in the numbers, not a recommendation of either stock.
Side by side
| MANGALAM | SUNREST | |
|---|---|---|
| Price | ₹29.21 | ₹37.3 |
| Market cap | ₹46 cr | ₹17 cr |
| P/E | — | 4.3 |
| P/B | — | 0.8 |
| ROE | -35.2% | 22.4% |
| ROCE | -22.8% | 25.9% |
| Debt / equity | 1.08 | 0.85 |
| Operating margin | -11.5% | 11.3% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | -14.7% | 43.4% |
| Profit growth, 3 years (yearly) | — | 26.3% |
| 1-year return | -55.7% | -11.2% |
| Revenue, last 12 months | ₹232 cr | ₹71 cr |
| Net profit, last 12 months | ₹-38 cr | ₹4 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹-8 cr | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 35.65% | — |
| Health check | Weak (0/10) | Strong (7.7/10) |
Common questions
Which earns a higher return on equity?
Sunrest Lifescience Limited (22.4% against -35.2%).
Which carries more debt?
Mangalam Drugs & Organics Ltd. has the higher debt-to-equity ratio (1.08 against 0.85).